TD Cowen Upgrades UnitedHealth to Buy with Increased Price Target

TD Cowen has upgraded UnitedHealth (UNH) from 'hold' to 'buy,' raising its price target to $455 from $402. This upgrade follows a 14% decline in the stock over the last three months, driven largely by regulatory concerns regarding new anti-fraud rules proposed by the Centers for Medicare & Medicaid Services (CMS). Analyst Ryan Langston suggests that UnitedHealth is positioned for mid-to-high teens EPS growth through 2028. The bullish outlook is predicated on a recovery in Optum Health, margin expansion, and the commercialization of AI-driven products within Optum Insight. Despite regulatory scrutiny over Medicare Advantage, TD Cowen believes the company's patient care business remains a strong driver for long-term value.

By Liz Napolitano · CNBC ·

TD Cowen Upgrades UnitedHealth to Buy with Increased Price Target

Tickers: $UNH

Topics: Earnings Growth Forecast Medicare Advantage Optum Health Stock Upgrade

Read the full article at CNBC

More World news